Did You Know...
...that the Eveready Battery began as an invention called the "electric flowerpot," which was a tube with a battery and light bulb inside? The idea was to fasten this gizmo to the side of a flowerpot so it would illuminate the flowers from the bottom. The idea died on the vine and the businessman who licensed the flower pot, Conrad Huber, was left with a pile of useless tubes -- until he found a way to market them as batteries to light the world!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8119697 | Anti-nausea and anti-vomiting activity of cannabidiol compounds The present invention relates the use of certain cannabidiol derivatives and of their dimethyl heptyl homologs (CBD-DMH) in the treatment of nausea, in particular chemotherapy-induced nausea, and of anti vomiting activity. The present invention relates also to the u... | 02/21/2012 |
| 8058315 | Foaming alcohol compositions with selected dimethicone surfactants Foaming alcohol compositions with selected dimethicone surfactants are disclosed. The dimethicone surfactants are PEG-8 to PEG-12 linear dimethicone surfactants and in particular PEG-10 linear dimethicone surfactant. The compositions are useful as antimicrobial prod... | 11/15/2011 |
| 8048929 | Hepatitis A viricide The invention relates to agents which combat the hepatitis A virus, containing only minimal amounts of chlorine-containing and/or chlorine cleaving active ingredients, or none of said substances. The inventions also relates to the use of these agents and to a method... | 11/01/2011 |
| 7872051 | Antiviral composition comprising p-menthane-3,8-diol The use of p-menthane-3,8-diol (PMD) in the manufacture of a medicament for use as an antiviral agent. The use of PMD in the manufacture of a medicament to destroy or inactivate viruses. The use of PMD, in vitro, as an antiviral or virucidal agent. The use of PMD in... | 01/18/2011 |
| 7750052 | Method for producing a water-alcohol solution and products based thereon The present invention relates to the field of food industry, where it may be used for producing alcoholic products, to pharmacology for producing infusions tinctures and extracts or preparations containing aqueous-alcoholic solutions as pharmaceutically acceptable m... | 07/06/2010 |
| 7678834 | Substituted 4-aminocyclohexanol compounds 4-aminocyclohexanol compounds, processes for their preparation, pharmaceutical formulations comprising these compounds and the use of substituted 4-aminocyclohexanol compounds for the preparation of pharmaceutical formulations and for the treatment of diverse indica... | 03/16/2010 |
| 7662863 | Therapeutic agent for the use in reducing alcohol intoxication and reducing or eliminating the negative side effects associated with alcohol ingestion A therapeutic method and associated compound for ameliorating alcohol intoxication and preventing and/or reducing hangover symptoms. Glucaric acid, any salt thereof, and/or any derivative or metabolized form thereof is provided in therapeutic dosage, before and/or a... | 02/16/2010 |
| 7659313 | Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals The present invention relates generally to methods and related compositions using flavonoids and/or indanes extracted from the stems and leaves of C. quadrangularis to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals. By exa... | 02/09/2010 |
| 7550511 | Compositions that bind antiterminator RNA and assay for screening for such compositions Compounds that are selective binding agents specific for RNA secondary and tertiary structures and a fluorescence assay for detecting the binding of small molecules to T-box antiterminator model mRNAs. The compounds include novel tri-substituted oxazolidinones and a... | 06/23/2009 |
| 7439386 | Therapeutic substituted cyclopentanones Compounds are disclosed herein comprising or a pharmaceutically acceptable salt, or a metabolite or a prodrug thereof; wherein a dashed line indicates the presence or absence of a bond; Y, A, an... | 10/21/2008 |
| 7439372 | Therapeutic compounds A compound having a structure is disclosed herein. Compositions, medicaments, and therapeutic methods related thereto are also disclosed. ... | 10/21/2008 |
| 7414044 | Use of targeted oxidative therapeutic formulation in treatment of type 2 diabetes A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as d... | 08/19/2008 |
| 7399790 | Virucidal compositions A method of inactivating enveloped virus comprises contacting said virus with a virucidally effective amount of a composition comprising a C1 to C3 monohydroxy alcohol or a C3 to C4 diol and a sufficient amount of an acid to adjust the pH of the composition to below... | 07/15/2008 |
| 7384920 | Use of stilbene compounds in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus-associated diseases This invention relates to a new use of stilbene derivatives or pharmaceutically acceptable salts thereof, especially in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus associated diseases. ... | 06/10/2008 |
| 7375135 | Fatty acid derivatives; preparation and uses thereof The invention concerns novel molecules, their preparation and their uses, in particular in the field of human and veterinary medicine and cosmetics. The inventive compounds are partly fatty acid derivatives and exhibit advantageous pharmacological and cosmetic prope... | 05/20/2008 |
| 7368132 | Glyoxal/zinc fixative This invention provides compositions and methods for fixing a biological sample, particularly fecal samples for diagnosis of parasitic infection. The fixative composition of the present invention comprises glyoxal (pyruvate aldehyde) and zinc sulfate and permits sta... | 05/06/2008 |
| 7361678 | Azole derivatives and fused bicyclic azole derivatives as therapeutic agents This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the... | 04/22/2008 |
| 7357923 | Topical medicament for skin injuries and disorders A topical product for the application to the skin or mucosal surfaces comprises yellow beeswax in an oleaginous base of, e.g., olive oil, sunflower oil, almond oil, cod liver oil, castor oil, along with an excipient vehicle. The product is useful in connection with ... | 04/15/2008 |
| 7348310 | Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them The invention relates to aplidine derivatives of the general formula: which are useful for the treatment of tumors. ... | 03/25/2008 |
| 7338968 | Thiadiazoles AS CXC- and CC- chemokine receptor ligands Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl... | 03/04/2008 |
| 7326730 | Aminoadamantane derivatives as therapeutic agents The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives and composi... | 02/05/2008 |
| 7314611 | Solution and method for treating organic waste An odor control product for treating digestible and odiferous organic waste to minimize odors includes about 12.5% adipic acid, about 70% alcohol, about 0.5% eucalyptus oil, and the remainder water. A variation of the product for use in an atomization system include... | 01/01/2008 |
| 7300793 | Method for preventing the adhesion of particles A method for the prevention of the adhesion of particles, in particular cells and cellular components in solution to surfaces, characterized in that to the solution is added at least one polyalcohol. ... | 11/27/2007 |
| 7294651 | Inhibition of exoprotein production using isoprenoid compositions Methods and compositions for inhibiting the production of exotoxins are disclosed. The compositions include an effective amount of an isoprenoid inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. ... | 11/13/2007 |
| 7282523 | Pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease The invention provides methods for treating beta-Amyloid protein-induced disease, pharmaceutical compositions and compounds useful for the same, and the use of these compounds for the manufacture of a medicament for treating the same. More particularly, the inventio... | 10/16/2007 |
| 7276631 | Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists The present disclosure relates to chemical compounds and their use in human therapy. A specific embodiment of the disclosure relates to compounds of Formula (I); or an isomer, a pharmaceutically acceptable salt or solvate thereof or a pharmaceutically acceptable for... | 10/02/2007 |
| 7267822 | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation Novel oligonucleotides comprising a sequence derived by a computer program are provided for inhibiting cytotoxic activity of lymphocytic cells, inhibiting production of inflammatory cytokines and inflammatory responses associated with those cytokines, inhibiting the... | 09/11/2007 |
| 7268163 | Method for treating an inflammation or lesion caused by a virus A method for treating an inflammation or lesion caused by herpesvirus, comprising topically applying to said inflammation or lesion a composition consisting essentially of a C1 to C3 monohydroxy alcohol or a C2 to C4 diol and a sufficient amount of an acid to adjust... | 09/11/2007 |
| 7268165 | Enhanced activity alcohol-based antimicrobial compositions Antimicrobial compositions which can be used wherever disinfecting compositions are needed, such as in a hospital, healthcare industry, workplace, recreational facility, home or similar environment. The antimicrobial compositions are particularly useful as a topical... | 09/11/2007 |
| 7258876 | Topical composition for treating infectious conditions of skin and mucosa A topically applied composition that is used to treat infections caused by pathogenic organisms. The composition contains melaleuca alternifolia extract oil to reduce the present population of the pathogenic organisms at the infection site. The composition al... | 08/21/2007 |
| 7253201 | Small molecule inhibitors of necrosis The invention features methods for decreasing necrosis. The invention also features methods for treating a subject with a condition in which necrosis occurs. The invention further features chemical compounds used to decrease necrosis. ... | 08/07/2007 |
| 7247602 | Agrochemical formulation aid composition and uses thereof There is provided an agrochemical formulation aid composition for use with technical grade, manufacturing concentrates or pre-formulated Agricultural Chemicals/pesticides, fertilizers and the like comprising about 1 to 99 parts by weight of monocarbamide dihydrogen ... | 07/24/2007 |
| 7232574 | Long chain alcohols provided in edible oils The present invention provides a method for incorporating long chain alcohols into edible oils. The long chain alcohol/edible oil admixture is then suitable for use in preparation of various foods. The long chain alcohol is added by the introduction of energy and in... | 06/19/2007 |
| 7232820 | Thiadiazole-amine compounds for the treatment of neurodegenerative disorders The present invention relates to compounds of the Formula I wherein R1, R3, R5, R7, X, Y and U are as defined. Compounds of the Formula I have activity inhibiting produ... | 06/19/2007 |
| 7226610 | Compositions and methods for the treatment and prevention of disease in plants Non-toxic, naturally derived and economical compositions for treating and preventing bacterial or fungal disease in plants, especially citrus canker, wherein such compositions include various combinations of d-limonene, wax and monohydric alcohol are provided. Metho... | 06/05/2007 |
| 7223746 | Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists The invention relates to the use of derivatives of E-type prostaglandins as EP2 agonists, in general, and, in particular as ocular hypotensives. The PGE derivatives used in accordance with the invention are represented by the following formula I: | 05/29/2007 |
| 7214394 | Policosanol compositions, extraction from novel sources, and uses thereof Compositions, novel isolation sources and processes, and uses for unique policosanol containing compositions are disclosed. Seed and vegetable processing byproduct and/or “waste” streams are disclosed as containing policosanols with various relative amounts of t... | 05/08/2007 |
| 7211644 | Diagnostic markers of human female infertility Methods and reagents for the diagnosis of female infertility, prognostic indicators for female infertility, compounds for the treatment of female infertility, compounds and methods for contraception. Methods and compounds are based on the levels of ebaf in endometri... | 05/01/2007 |
| 7208519 | Pesticidal compounds and compositions The invention includes a pesticidal compound comprising at least one organic phenolic compound and at least one salt comprising a divalent cation. Preferably, the organic phenolic compound is chosen from Carvacrol, thymol or combinations thereof; and is derived from... | 04/24/2007 |
| 7192601 | Antimicrobial and sporicidal composition Germicidal compositions with enhanced activity towards killing microbiological spores and vetgetative cells comprising certain quaternary ammonium compounds (QACs), phenolic compounds, monohydric alcohols, hydrogen peroxide, iodine, triclocarban, triclosan or combin... | 03/20/2007 |
